AzTrials
AzTrials

ObesityC3PONCT03998046

Coordinating Pragmatic Primary Care Population Management for Obesity

A study testing Outreach Support for Weight Loss Goal Setting and Self-Weighing, Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions and Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support in people with Obesity and Cardiovascular Risk Factor, run by Northwestern University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The C3PO pilot and feasibility study uses a rigorous, mixed-method research design to provide information needed to refine and implement a technology-mediated primary care outreach intervention approach before conducting a larger and more definitive future intervention trial. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obesity, Cardiovascular Risk Factor
What is being tested?
Outreach Support for Weight Loss Goal Setting and Self-Weighing, Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions and Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
16 Dec 2019to 30 Jun 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • BMI ≥ 27 kg/m2
  • ≥ 1 CVD risk condition (hypertension, dyslipidemia, prediabetes or type 2 diabetes)
  • Registered in Northwestern Medical Group's EpicCare MyChart patient portal
  • Received and completed MyChart survey of weight loss interest
  • Affirms interest in weight loss goal setting and receiving additional resource information and electronic Scale.

Who cannot join

  • Evidence of hospitalization in past 30 days
  • Most recent blood pressure >180/105
  • Cancer (non-skin) treatment within the past 2 years
  • Encounter diagnosis for hypoglycemia in past 30 days
  • Actively receiving care from the bariatric surgery service or a bariatric medication order in the past 100 days

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Northwestern Medicine

    Chicago, Illinois, 60611

Other trials in United States

About this study

The C3PO pilot and feasibility study uses a rigorous, mixed-method research design to provide information needed to refine and implement a technology-mediated primary care outreach intervention approach before conducting a larger and more definitive future intervention trial.

Read the detailed description

This study will implement and evaluate a pragmatic and generalizable framework for population management of obesity by the primary care sector. With patient and other stakeholder input, the C3PO intervention will be designed to leverage existing primary care professionals and technologies to implement a scalable framework for population obesity management that coordinates primary care services with extant intensive lifestyle interventions in community settings to achieve wider reach and population-level effectiveness. A rigorous, mixed-method pilot and feasibility study will provide critical information needed to optimize the intervention design and prepare us for a larger and definitive future trial.

Being tested
Outreach Support for Weight Loss Goal Setting and Self-Weighing, Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions, Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support
Keywords
overweight, obesity, prediabetes, type 2 diabetes, hypertension, dyslipidemia, cardiovascular risk factor, adult, primary care
Medical subject headings
Obesity, Overweight, Prediabetic State, Diabetes Mellitus, Type 2, Hypertension, Dyslipidemias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Outreach Support for Weight Loss Goal Setting and Self-WeighingBehavioural

    Patients will receive a MyChart activation message assessing weight loss interest that invites them to complete a MyChart Survey encouraging a weight loss goal using principles adapted from Brief Action Planning. Patients will then receive a cellular network-enabled electronic body weight scale, and weighing data transmitted by the scale will be received and integrated into the electronic health record for access by the patient's primary care team.

  • Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle InterventionsBehavioural

    Patients will receive via MyChart information and decision support designed to encourage linkages to and participation in intensive lifestyle programs available in the community. Patients who request information or clinical referrals will also receive them. "Refreshes" of community linkage information will be sent by MyChart every 1 to 4 weeks.

  • Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach SupportBehavioural

    Data received into the electronic health record from the cellular network-enabled electronic scale will categorize each patient based on their daily self-weighing behaviors and rate of progress towards their weight loss goal. Patients who are not engaged in daily self-weighing or are not making progress towards their goal will receive more intensive outreach support in the form of automated weekly MyChart problem solving messages, more frequent encouragement to access a broader array of community resources, and telephonic support from a nurse care coordinator who is an existing member of the primary care team. Support from this nurse care coordinator will be facilitated by the incorporation of each patient's self-weighing data into an EpicCare patient dashboard accessible to the nurse coordinator and other members of the care team

Study groups in NCT03998046
Study groupRoleWhat they receive
Basic Resources and ServicesActive comparatorPatients will receive outreach engagement in goal setting via MyChart, an electronic scale, telemonitoring of self weighing, and information about linkages to extant intensive lifestyle interventions in the community
Receives: Behavioral: Outreach Support for Weight Loss Goal Setting and Self-Weighing; Behavioral: Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions
Coordinated Primary Care Population Management (C3PO)ExperimentalPatients will receive outreach engagement in goal setting via MyChart, an electronic scale, telemonitoring of self weighing, information about linkages to extant intensive lifestyle interventions, and outreach MyChart messages that are tailored to each individual's pattern of self-weighing and progress towards their weight goal, and more intensive support from a primary care nurse based on self-weighing behavior and weight loss success.
Receives: Behavioral: Outreach Support for Weight Loss Goal Setting and Self-Weighing; Behavioral: Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions; Behavioral: Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants Who Achieved 5% Weight Loss Goal at 6 Months

    Proportion of Participants who Reach a 5% Weight Loss Goal at 6 Months, calculated as the percent of all participants for whom the following calculation is greater than or equal to 5%: (Baseline body mass (kg) - Body mass measured at 6 months (kg))/(Baseline body mass (kg))

    Measured: Baseline - 6 Months

Secondary outcomes (8)
  1. Costs to Implement the Intervention

    Costs (US$) of Intervention Components, including the costs to fund personnel efforts, technology, and other intervention components

    Measured: Baseline - 12 Months

  2. Change in Hemoglobin A1C

    Mean change in Hemoglobin A1C levels (DCCT%) from baseline to 12 months

    Measured: Baseline - 12 Months

  3. Change in Systolic Blood Pressure

    Mean change in systolic blood pressure (mmHg) from baseline to 12 months

    Measured: Baseline - 12 Months

  4. Change in Total Cholesterol

    Mean change in total cholesterol concentration (mg/dL) from baseline to 12 months

    Measured: Baseline - 12 Months

  5. Change in Non-HDL Cholesterol

    Mean change in non-HDL cholesterol concentration (mg/dL) from baseline to 12 months

    Measured: Baseline - 12 Months

  6. Body Mass Change at 6 Months

    Mean Change in Body Mass (kg) from Baseline to 6 Months

    Measured: Baseline - 6 Months

  7. Body Mass Change at 12 Months

    Mean Change in Body Mass (kg) from Baseline to 12 Months

    Measured: Baseline - 12 Months

  8. Number of Participants Who Achieved 5% Weight Loss Goal in 12 Months

    Proportion of Participants who Reach a 5% Weight Loss Goal at 12 Months, calculated as the percent of all participants for whom the following calculation is greater than or equal to 5%: (Baseline body mass (kg) - Body mass measured at 12 months (kg))/(Baseline body mass (kg))

    Measured: Baseline - 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2019
  2. Study start16 Dec 2019
  3. Primary completion30 Jun 2020
  4. Study completion30 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
The active intervention "C3PO" involves enhanced use of pragmatic electronic health record system technologies and members of the primary care workforce to increase supportive accountability and problem solving support for weight loss goals and behavior, which in turn will lead to routine self-weighing, increased take up into intensive community programs, and increased adoption and maintenance of healthy eating and physical activity behaviors that collectively lead to greater weight loss at a population level.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03998046
Sponsor's protocol ID
STU00207153
Other IDs
R34DK114773
Acronym
C3PO
Status last verified
Jan 2022
First submitted
21 Jun 2019
Last updated
22 Feb 2022
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ackermann RT, Cameron KA, Liss DT, Dolan N, Aikman C, Carson AR, Harris SA, Doyle K, Cooper AJ, Hitsman B. Hybrid Health IT and Telehealth-Delivered Behavioral Weight Loss Services for Primary Care Patients With Cardiovascular Risk Factors: Intervention Component Design and Pragmatic Randomized Feasibility Trial. JMIR Mhealth Uhealth. 2025 Oct 22;13:e58722. doi: 10.2196/58722.

    PubMed 41126509

Questions about this trial

What is this clinical trial studying?

A study testing Outreach Support for Weight Loss Goal Setting and Self-Weighing, Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions and Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support in people with Obesity and Cardiovascular Risk Factor, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 22 Feb 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants Who Achieved 5% Weight Loss Goal at 6 Months (time frame: Baseline - 6 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03998046, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in